The Treatment of hypertension in the elderly

Journal of Clinical Hypertension

Volumn 10, Issue 1, 2008, Pages 58-68

  Moser, Marvin ^a   Cushman, William C ^a   Ziegler, Michael G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; HUMAN; HYPERTENSION; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PHYSIOLOGY; SODIUM INTAKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; HUMANS; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; PATIENT COMPLIANCE; SODIUM, DIETARY; TREATMENT OUTCOME;

EID: 40049089138     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2007.07903.x     Document Type: Article

References (6)

1. Moser M. Treatment of hypertension in the very elderly: a clinician's point of view. J Clin Hypertens (Greenwich). 2003;5(5):310-312.
2. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in highrisk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALL HAT). JAMA. 2002;288:2981-2997.
3. Leenen FHH, Nwachuku CE, Black HR, et al, for the ALLHAT Collaborative Research Group. Clinical events in high-risk hypertensive patients randomized to calcium channel blocker vs ACE-inhibitor in ALL HAT. Hypertension. 2006;48:374-384.
4. Cushman WC, Ford CE, Cutler JA, et al, for the ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4:393-404.
5. Barzilay J, Grimm R, Cushman W, et al. Getting to goal blood pressure: why reserpine deserves a second look. J Clin Hypertens (Greenwich). 2007;9:591-594.
6. Moser, M. Clinical Management of Hypertension. 7th ed. Caddo, OK: Professional Communications; 2005.